Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fulcrum Therapeutics

6.53
-0.0750-1.14%
Volume:53.78K
Turnover:357.33K
Market Cap:352.21M
PE:-794.67
High:6.69
Open:6.69
Low:6.31
Close:6.60
Loading ...

Fulcrum Therapeutics (FULC) Receives a Buy from Oppenheimer

TIPRANKS
·
3 hours ago

Fulcrum Therapeutics Shares Rise After Cantor Fitzgerald Upgrade

MT Newswires Live
·
19 hours ago

Fulcrum Therapeutics Raised to Overweight From Neutral by Cantor Fitzgerald

Dow Jones
·
Yesterday

Cantor Fitzgerald Upgrades Fulcrum Therapeutics to Overweight From Neutral, Price Target is $10

MT Newswires Live
·
Yesterday

CAMP4 Therapeutics Reports Q1 2025 Financial Results: Net Loss Slightly Decreases to $12.4 Million

Reuters
·
14 May

Fulcrum Therapeutics Inc. to Participate in H.C. Wainwright BioConnect Investor Conference

Reuters
·
09 May

Piper Sandler Sticks to Its Buy Rating for Fulcrum Therapeutics (FULC)

TIPRANKS
·
02 May

Fulcrum Therapeutics Inc (FULC) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions and ...

GuruFocus.com
·
02 May

Q1 2025 Fulcrum Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
02 May

Fulcrum Therapeutics Reports Q1 2025 Progress and Stability

TIPRANKS
·
02 May

Fulcrum Therapeutics’ Positive Earnings Call Highlights

TIPRANKS
·
02 May

Fulcrum Therapeutics price target lowered to $12 from $14 at Oppenheimer

TIPRANKS
·
02 May

Fulcrum Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Fulcrum Therapeutics Inc. Unveils Strategic Focus on Gene Expression Modification for Rare Diseases in Latest Corporate Presentation

Reuters
·
01 May

Fulcrum Therapeutics Q1 EPS $(0.28) Beats $(0.30) Estimate. Cash And Equivalents $226.6M

Benzinga
·
01 May

BRIEF-Fulcrum Therapeutics Q1 Basic EPS USD -0.28

Reuters
·
01 May

Fulcrum Therapeutics Q1 Basic EPS USD -0.28

THOMSON REUTERS
·
01 May

Fulcrum Therapeutics Q1 Operating Income USD -20.403 Million

THOMSON REUTERS
·
01 May

Fulcrum Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview

Reuters
·
29 Apr

Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET

GlobeNewswire
·
24 Apr